Adaptive Phage Therapeutics To Prevent The Spread of Infection
One of the healthcare problems that has accelerated due to COVID has been bacterial infections that are increasingly resistant to antibiotics – local startup Adaptive Phage Therapeutics (APT) is working to address this crisis. APT is a clinical-stage company founded with help from TEDCO, a Maryland
LEARN MORE